ARVIND PANDURANG KAMATH

Allopathic & Osteopathic Physicians|Internal Medicine VALLEY, AL NPI 1619067014

General Payments — all program years on this page

$2,070.45

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 88
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $196.11 across 11 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $196.1111

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $62.593
Lilly USA, LLC $30.002
GlaxoSmithKline, LLC. $27.312
Mylan Specialty L.P. $21.581
Novo Nordisk AS $20.841
Acerta Pharma LLC $18.281
E.R. Squibb & Sons, L.L.C. $15.511

By program year

Program yearAmountRecords
2018 $15.501
2019 $347.8511
2020 $401.7619
2021 $413.6814
2022 $309.7415
2023 $385.8117
2024 $196.1111

Records — PY2024 (11)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097472852 Novo Nordisk Inc $20.84 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101378580 E.R. Squibb & Sons, L.L.C. $15.51 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104023993 ABBVIE INC. $22.44 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104023995 ABBVIE INC. $15.09 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104023997 ABBVIE INC. $25.06 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105885763 AstraZeneca Pharmaceuticals LP $18.28 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116035866 GlaxoSmithKline, LLC. $14.14 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116128977 GlaxoSmithKline, LLC. $13.17 09/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136054296 Lilly USA, LLC $15.00 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136055164 Lilly USA, LLC $15.00 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147297267 Mylan Specialty L.P. $21.58 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.